Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2008

Secord AA, Blessing JA, Armstrong DK, Rodgers WH, Miner Z, Barnes MN, et al. Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study. Gynecol Oncol. 2008;108(3):493-9.

J Holsinger M, Magro C, Allen C, Powell D, Agrawal A. Eosinophilic angiocentric fibrosis. J Otolaryngol Head Neck Surg. 2008;37(5):E155-8.

Patnaik MM, Hammerschmidt D, van Burik J-, Jessurun J, Smyth P. Lepromatous leprosy masquerading as acute sarcoidosis: a case report and literature review. Minn Med. 2008;91(11):30-3.

Chen Y-, Tu JJ, Kao J, Zhou XK, Chen Y-. Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma. Arch Pathol Lab Med. 2008;132(2):224-31.

Nassar A, O'Reilly K, Cohen C, Siddiqui MT. Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations. Diagn Cytopathol. 2008;36(3):142-8.

Mizuguchi Y, Chen J, Seshan SV, Poppas DP, Szeto HH, Felsen D. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2008;295(5):F1545-53.

Ali S, Gattuso P, Howard A, Mosunjac MB, Siddiqui MT. Adult granulosa cell tumor of the ovary: fine-needle-aspiration cytology of 10 cases and review of literature. Diagn Cytopathol. 2008;36(5):297-302.

Mertz KD, Demichelis F, Sboner A, Hirsch MS, Dal Cin P, Struckmann K, et al. Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. Int J Cancer. 2008;123(3):569-76.

Jais J-, Haioun C, Molina TJ, Rickman DS, De Reynies A, Berger F, et al. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab. Leukemia. 2008;22(10):1917-24.

J Babu R, M Seibenhener L, Peng J, Strom A-, Kemppainen R, Cox N, et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem. 2008;106(1):107-20.